AMERICAN SHARED HOSPITAL SERVICES Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $2.89 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-04-04
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $2.89, a 93.96% increase from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $1.49, a 35.45% increase from fiscal 2021.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $1.10, a 41.03% increase from fiscal 2020.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $0.78, a 49.35% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2023-12-31 | $2.89 10-K · filed 2025-04-04 |
| 2022-12-31 | $1.49 10-K · filed 2024-04-01 |
| 2021-12-31 | $1.10 10-K · filed 2023-03-31 |
| 2020-12-31 | $0.78 10-K · filed 2022-03-30 |
| 2019-12-31 | $1.54 10-K · filed 2021-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |